Small cell lung cancer that has been diagnosed and treated early may possibly be cured. Small cell lung cancer may also progress rapidly, in which case treatment is focused on managing the symptoms.

Treatment for small cell lung cancer depends on the stage. Stages are used to describe how much the cancer has worsened or spread.

Stages and Treatments

There are two main categories of small cell lung cancer. Treatment options for small cell lung cancer are discussed in more detail below.

1. Limited-stage small cell lung cancer – In this stage of small cell lung cancer, the cancer is in the lung. The lung cancer and may also spread to the area between the lungs or the lymph nodes above the collarbone.

Treatment for limited-stage small cell lung cancer may include:

• Chemotherapy
• Radiation therapy
• Surgery

2. Extensive-stage small cell lung cancer – In this stage of small cell lung cancer, the cancer has spread outside of the lung to the area between the lungs, the lymph nodes above the collarbone, or other places in the body.

Treatment for extensive-stage small cell lung cancer may include:

• Immunotherapy
• Chemotherapy
• Radiation therapy

Types of Treatments

There are a variety of treatment options for small cell lung cancer, which may include a combination of:

Surgery – Surgery for limited-stage small cell lung cancer may be performed if the cancer is in only one lung and nearby lymph nodes. However, small cell lung cancer is most often found in both lungs; therefore, surgery alone is not frequently used. If surgery is performed, the surgeon will remove all visible lung cancer and the adjacent lymph nodes. Surgery may be used in combination with chemotherapy and/or radiation therapy.

Chemotherapy – Chemotherapy uses drugs that kill cancer cells or stop them from forming and can be given by pills, directly into a vein, in the spinal fluid, or directly into an organ or cavity. Chemotherapy drugs used for small cell lung cancer include platinum-based chemotherapy, with etoposide combined with cisplatin or carboplatin, or irinotecan. Chemotherapy may be used in combination with surgery and/or radiation therapy.

Radiation therapy – Radiation therapy uses high-energy doses of radiation, protons, or other radiation to kill cancer cells. External radiation therapy directs the radiation at the cancer. Radiation therapy may be used to treat small cell lung cancer or as a palliative therapy to help relieve pain or symptoms.

Preventative radiation therapy, also called prophylactic cranial irradiation, may be used for small cell lung cancer to reduce the risk of cancer spread to the brain.

Immunotherapy, also called biologics – Immunotherapy uses a patient’s immune system, or the body’s own defenses, to attack cancer cells. Immunotherapy for the treatment of advanced small cell lung cancer includes immune checkpoint inhibitors, such as ipilimumab, pembrolizumab, nivolumab, atezolizumab, and durvalumab.

Supportive therapy – Patients with small cell lung cancer may need assistance with breathing, which includes the use of bronchodilators and supplemental oxygen therapy.

Palliative Care

In addition to standard treatments, patients with advanced small cell lung cancer may also be treated with palliative care. Palliative care is used to relieve pain and other symptoms to make a patient more comfortable.

New, Experimental Treatments

Capmatinib (Tabrecta) is a selective MET inhibitor that was recently approved by the FDA in 2020 for the treatment of small cell lung cancer.

Long-Term Follow Up

Ongoing, long-term follow-up is an essential part of the treatment for patients with small cell lung cancer because the cancer often reoccurs even after it has been treated.

Sources

This content was written by the MediFind Medical Team. Last updated: 6/9/2022

Medications for Small Cell Lung Cancer (SCLC)

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Small Cell Lung Cancer (SCLC).

Found 7 Approved Drugs for Small Cell Lung Cancer (SCLC)

Etopophos

Generic Name
Etoposide

Etopophos

Generic Name
Etoposide
ETOPOPHOS is a topoisomerase inhibitor indicated for the treatment of patients with: Refractory testicular tumors, in combination with other chemotherapeutic drugs. ( 1 ) Small cell lung cancer, in combination with cisplatin, as first-line treatment. ( 1 )

Hycamtin

Generic Name
Topotecan

Hycamtin

Generic Name
Topotecan
HYCAMTIN ® capsules are indicated for the treatment of relapsed small cell lung cancer (SCLC) in patients with a prior complete or partial response and who are at least 45 days from the end of first-line chemotherapy. HYCAMTIN capsules is a topoisomerase inhibitor indicated for treatment of patients with relapsed small cell lung cancer (SCLC). ( 1 )

Atezolizumab

Brand Names
Tecentriq, Tecentriq Hybreza

Atezolizumab

Brand Names
Tecentriq, Tecentriq Hybreza
TECENTRIQ is a programmed death-ligand 1 (PD-L1) blocking antibody indicated: Non-Small Cell Lung Cancer (NSCLC) as adjuvant treatment following resection and platinum-based chemotherapy for adult patients with Stage II to IIIA NSCLC whose tumors have PD-L1 expression on ≥ 1% of tumor cells, as determined by an FDA-approved test.

Imfinzi

Generic Name
Durvalumab

Imfinzi

Generic Name
Durvalumab
IMFINZI is a programmed death-ligand 1 (PD-L1) blocking antibody indicated: in combination with platinum-containing chemotherapy as neoadjuvant treatment, followed by IMFINZI continued as a single agent as adjuvant treatment after surgery, for the treatment of adult patients with resectable (tumors ≥ 4 cm and/or node positive) non-small cell lung cancer (NSCLC) and no known epidermal growth factor receptor (EGFR) mutations or anaplastic lymphoma kinase (ALK) rearrangements.

Zepzelca

Generic Name
Lurbinectedin

Zepzelca

Generic Name
Lurbinectedin
ZEPZELCA is an alkylating drug indicated: in combination with atezolizumab or atezolizumab and hyaluronidase-tqj, for the maintenance treatment of adult patients with extensive-stage small cell lung cancer whose disease has not progressed after first-line induction therapy with atezolizumab or atezolizumab and hyaluronidase-tqjs, carboplatin and etoposide.
Showing 1-5 of 7
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances